SFMBT1 Antibodies

Santa Cruz Biotechnology offers a broad range of SFMBT1 monoclonal antibodies for research applications. SFMBT1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SFMBT1, or Scm-like with four MBT domains 1, plays a crucial role in regulating gene expression and is involved in developmental processes and cellular differentiation. The significance of SFMBT1 in epigenetic regulation makes it a key target for studies related to cancer and other diseases. Understanding SFMBT1 function can provide insights into the mechanisms of cellular regulation and potential therapeutic approaches. SFMBT1 monoclonal antibodies enable precise detection and analysis of protein expression patterns across various experimental conditions. Researchers can utilize SFMBT1 monoclonal antibodies to investigate protein-protein interactions and cellular localization patterns. Advanced research techniques incorporating SFMBT1 monoclonal antibodies help unlock new discoveries in molecular biology and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by facilitating breakthrough research in cellular and molecular biology.